These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35914625)

  • 1. Task-independent acute effects of delta-9-tetrahydrocannabinol on human brain function and its relationship with cannabinoid receptor gene expression: A neuroimaging meta-regression analysis.
    Gunasekera B; Davies C; Blest-Hopley G; Veronese M; Ramsey NF; Bossong MG; Radua J; Bhattacharyya S;
    Neurosci Biobehav Rev; 2022 Sep; 140():104801. PubMed ID: 35914625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species.
    Borgan F; Beck K; Butler E; McCutcheon R; Veronese M; Vernon A; Howes OD
    Psychopharmacology (Berl); 2019 Nov; 236(11):3257-3270. PubMed ID: 31165913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the role of CB
    Li X; Hempel BJ; Yang HJ; Han X; Bi GH; Gardner EL; Xi ZX
    Eur Neuropsychopharmacol; 2021 Feb; 43():38-51. PubMed ID: 33334652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ
    Gunasekera B; Davies C; Martin-Santos R; Bhattacharyya S
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):636-645. PubMed ID: 33414100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
    Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
    J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor mechanisms underlying the CNS effects of cannabinoids: CB
    Hempel B; Xi ZX
    Adv Pharmacol; 2022; 93():275-333. PubMed ID: 35341569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism.
    Ranganathan M; Sewell RA; Carbuto M; Elander J; Schnakenberg A; Radhakrishnan R; Pittman B; D'Souza DC
    Psychopharmacology (Berl); 2014 Jun; 231(12):2385-93. PubMed ID: 24424782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Leu/Val
    Llinas Del Torrent C; Raïch I; Gonzalez A; Casajuana-Martin N; Lillo J; Rebassa JB; Ferreiro-Vera C; Sánchez de Medina V; Franco R; Navarro G; Pardo L
    J Chem Inf Model; 2023 Sep; 63(18):5927-5935. PubMed ID: 37644761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Δ(9)-tetrahydrocannabinol (THC) on human amniotic epithelial cell proliferation and migration.
    Yao JL; He QZ; Liu M; Chang XW; Wu JT; Duan T; Wang K
    Toxicology; 2018 Feb; 394():19-26. PubMed ID: 29191629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
    Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
    Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.
    Freedland CS; Whitlow CT; Miller MD; Porrino LJ
    Synapse; 2002 Aug; 45(2):134-42. PubMed ID: 12112406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans.
    Skosnik PD; Hajós M; Cortes-Briones JA; Edwards CR; Pittman BP; Hoffmann WE; Sewell AR; D'Souza DC; Ranganathan M
    Neuropharmacology; 2018 Jun; 135():412-423. PubMed ID: 29604295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain regional differences in CB1 receptor adaptation and regulation of transcription.
    Lazenka MF; Selley DE; Sim-Selley LJ
    Life Sci; 2013 Mar; 92(8-9):446-52. PubMed ID: 22940268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clarifying CB2 receptor-dependent and independent effects of THC on human lung epithelial cells.
    Sarafian T; Montes C; Harui A; Beedanagari SR; Kiertscher S; Stripecke R; Hossepian D; Kitchen C; Kern R; Belperio J; Roth MD
    Toxicol Appl Pharmacol; 2008 Sep; 231(3):282-90. PubMed ID: 18556036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
    Sim-Selley LJ; Martin BR
    J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol.
    McKinney DL; Cassidy MP; Collier LM; Martin BR; Wiley JL; Selley DE; Sim-Selley LJ
    J Pharmacol Exp Ther; 2008 Feb; 324(2):664-73. PubMed ID: 17967938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors.
    Bhattacharyya S; Egerton A; Kim E; Rosso L; Riano Barros D; Hammers A; Brammer M; Turkheimer FE; Howes OD; McGuire P
    Sci Rep; 2017 Nov; 7(1):15025. PubMed ID: 29101333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.
    D'Souza DC; Fridberg DJ; Skosnik PD; Williams A; Roach B; Singh N; Carbuto M; Elander J; Schnakenberg A; Pittman B; Sewell RA; Ranganathan M; Mathalon D
    Neuropsychopharmacology; 2012 Jun; 37(7):1632-46. PubMed ID: 22334121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC).
    Bossong MG; Jansma JM; Bhattacharyya S; Ramsey NF
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():53-69. PubMed ID: 24380726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.